Literature DB >> 439932

Intermittent treatment regimens in pulmonary tuberculosis.

M Zierski.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 439932     DOI： 10.1007/bf02713988

Source DB:  PubMed          Journal:  Lung        ISSN： 0341-2040            Impact factor:   2.584


× No keyword cloud information.
  55 in total

1.  Retreatment of chronic pulmonary tuberculosis with regimens including high and low doses of rifampicin in the intermittent phase recent and late results - a controlled comparison study.

Authors:  M Zierski; E Bek; H Bergson; A Kucharska; B Szelagowicz
Journal:  Bull Int Union Tuberc       Date:  1976

2.  [Comparative study (in a controlled therapeutic trial) of 3 intermittent regimens, after an initial period of daily administration, in the repeated treatment of pulmonary tuberculosis (results)].

Authors:  H Fraga; O Gomes; A Paz de Almeida; G Gerhardt; A C Santiago
Journal:  Bull Int Union Tuberc       Date:  1973-06

3.  [Double blind study of the toxicity of different doses of ethambutol given in an intermittent therapeutic regimen with streptomycin, isoniazide and ethambutol].

Authors:  H Eule; M Lucchesi; Z S Ozgen; M Zierski
Journal:  Bull Int Union Tuberc       Date:  1973-06

4.  General considerations in the choice and management of regimens of chemotherapy for pulmonary tuberculosis.

Authors:  W Fox
Journal:  Bull Int Union Tuberc       Date:  1972-02

5.  A controlled comparison of self-administered versus supervised treatment in Singapore.

Authors:  S Devi
Journal:  Bull Int Union Tuberc       Date:  1972-02

6.  [Comparison between regimes of rifampicin-isoniazid administered daily and administered twice a week (initial results of a comparative study conducted in 4 medical services of the Parisian region)].

Authors:  G Decroix; B Kreis; C Sors; J Birembaum; M Le Lirzin; G Canetti
Journal:  Rev Tuberc Pneumol (Paris)       Date:  1969 Sep-Oct

7.  Controlled trial of intermittent regimens of rifampicin plus isoniazid for pulmonary tuberculosis in Singapore.

Authors: 
Journal:  Lancet       Date:  1975-12-06       Impact factor: 79.321

Review 8.  Variations between individuals and populations in the acetylation of isoniazid and its significance for the treatment of pulmonary tuberculosis.

Authors:  G A Ellard
Journal:  Clin Pharmacol Ther       Date:  1976-05       Impact factor: 6.875

9.  A comparative study of daily and twice-weekly continuation regimens of tuberculosis chemotherapy, including a comparison of two durations of sanatorium treatment. 1. First report: the results at 12 months.

Authors: 
Journal:  Bull World Health Organ       Date:  1971       Impact factor: 9.408

10.  ACONCURRENT COMPARISON OF INTERMITTENT (TWICE-WEEKLY) ISONIAZID PLUS STREPTOMYCIN AND DAILY ISONIAZID PLUS PAS IN THE DOMICILIARY TREATMENT OF PULMONARY TUBERCULOSIS; TUBERCULOSIS CHEMOTHERAPY CENTRE, MADRAS.

Authors:  A LOTTE; F HATTON; S PERDRIZET; A ROUILLON
Journal:  Bull World Health Organ       Date:  1964       Impact factor: 9.408
View more
  2 in total

Review 1.  New Approaches and Therapeutic Options for Mycobacterium tuberculosis in a Dormant State.

Authors:  Santiago Caño-Muñiz; Richard Anthony; Stefan Niemann; Jan-Willem C Alffenaar
Journal:  Clin Microbiol Rev       Date:  2017-11-29       Impact factor: 26.132

2.  A lung image reconstruction from computed radiography images as a tool to tuberculosis treatment control.

Authors:  Marcela de Oliveira; Sergio Barbosa Duarte; Guilherme Giacomini; Paulo Câmara Marques Pereira; Lenice do Rosário de Souza; José Ricardo de Arruda Miranda; Diana Rodrigues de Pina
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2019-02-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.